Xeris Biopharma: Q1 Earnings Snapshot

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Tuesday reported a loss of $16.8 million in its first quarter.

On a per-share basis, the Chicago-based company said it had a loss of 12 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The company posted revenue of $33.2 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $30.8 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up